Minnesota began analyzing more samples from COVID-19 patients this fall than almost any state, intensifying its search for new coronavirus variants that could worsen illness or undermine vaccination.
Roughly 8% of Minnesota's 920,000 coronavirus infections have been sequenced to identify their genetic fingerprints, but public and private labs are now analyzing 20% to prevent any troubling variants from surging undetected.
At 2,000 genetic sequences per week, Minnesota is likely to detect a significant variant even if it exists in 0.1% of samples, said Sara Vetter, director of the state public health laboratory. "If something is circulating around in 1 in 1,000 [samples], we will find it."
The tighter safety net helps explain why Minnesota was the second state to identify an infection involving the omicron variant a week after it was discovered in South Africa. The infection involved a Hennepin County man who experienced mild COVID-19 symptoms Nov. 22 after attending a convention in New York.
Minnesota has submitted the third-most genomic sequencing results of coronavirus samples over the past 90 days to the GISAID open-access database, which allows for broader research for trends among the results. Colorado also was among the first five states to find omicron infections, and it ranked second.
"It could be coincidence ... but I don't think so," said Kenny Beckman, director of the University of Minnesota Genomics Center, which is part of the state's sequencing group.
Genomic sequencing this summer showed the shocking rate at which the fast-spreading alpha variant was swept aside by the faster-spreading delta variant. Surveillance was mundane by comparison this fall when delta turned up in 99% of samples.
"In three weeks, we went from no delta to almost all delta," Beckman said